Growth Metrics

Gossamer Bio (GOSS) Income from Continuing Operations (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Income from Continuing Operations data on record, last reported at 48221000.0 in Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 56.37% year-over-year to 48221000.0; the TTM value through Sep 2025 reached 158785000.0, down 114.95%, while the annual FY2024 figure was 56528000.0, 68.56% up from the prior year.
  • Income from Continuing Operations reached 48221000.0 in Q3 2025 per GOSS's latest filing, down from 38273000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 53667000.0 in Q2 2024 and bottomed at 59031000.0 in Q3 2022.
  • Average Income from Continuing Operations over 4 years is 39793666.67, with a median of 44744000.0 recorded in 2024.
  • Peak YoY movement for Income from Continuing Operations: surged 226.29% in 2024, then plummeted 171.32% in 2025.
  • A 4-year view of Income from Continuing Operations shows it stood at 57220000.0 in 2022, then increased by 9.2% to 51956000.0 in 2023, then skyrocketed by 36.43% to 33029000.0 in 2024, then plummeted by 46.0% to 48221000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 48221000.0 in Q3 2025, 38273000.0 in Q2 2025, and 39262000.0 in Q1 2025.